
Fillceft S 250mg/125mg Injection
Marketer
UVA Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Fillceft S 250mg/125mg Injection
Cefixime and Sulbactam injection, 250mg/125mg, combats bacterial infections by inhibiting microbial growth. Administered only by a healthcare provider, this combination medication requires adherence to the prescribed treatment schedule. Completing the full course is crucial; premature cessation may reduce effectiveness. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Severe side effects or allergic reactions (rash, itching, swelling, breathing difficulties) necessitate immediate medical attention. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, refrain from driving if experiencing dizziness or sleepiness. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Follow-up laboratory tests may be necessary to monitor treatment efficacy.
Primary Ingredients of Fillceft S 250mg/125mg Injection
No text was provided to rephrase. Please provide the text you wish to have rewritten.
Uses of Fillceft S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Fillceft S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Fillceft S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Fillceft S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Fillceft S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Fillceft S 250mg/125mg Injection, offer a dual antibiotic approach. Ceftriaxone, a key component, combats bacterial growth by disrupting their protective layers. Sulbactam, a beta-lactamase inhibitor, complements Ceftriaxone by counteracting bacterial resistance mechanisms, thus improving the antibiotic's overall effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Fillceft S 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefixime and Sulbactam 250mg/125mg injection is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Cefuroxime Axetil 250mg/125mg injection requires careful consideration when breastfeeding. Mothers should discontinue breastfeeding throughout treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Fillceft S 250mg/125mg Injection can potentially reduce alertness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Fillceft S 250mg/125mg Injection use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
For individuals with severe hepatic impairment, administering Fillceft S 250mg/125mg Injection requires careful consideration and potential dosage modification. Medical advice is necessary. Dosage alteration for Fillceft S 250mg/125mg Injection isn't advised for those experiencing mild to moderate liver dysfunction.
What if you forget to take Fillceft S 250mg/125mg Injection :
Should you forget a dose of Fillceft S 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Fillceft S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
